1 / 4

G-CSF Biosimilars Market Forecast to 2015

Bharat Book introduces a report "G-CSF Biosimilars Market Forecast to 2015". As the governments and private players around the world are stepping into the market, it is exhibiting bright prospects and immense opportunities to cash in on.

bharatbookseo
Télécharger la présentation

G-CSF Biosimilars Market Forecast to 2015

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. G-CSF Biosimilars Market Forecast to 2015 Bharat Book Bureauwww.bharatbook.com

  2. Summary  For the past few years, the biosimilars industry has been growing stupendously across the globe due to increasing healthcare costs and rising aging population. It is expected to evolve, to a great extent, from its current status. As per the estimations of our latest report, the global biosimilars market will expand at a CAGR of around 52% during 2010-2015. As the governments and private players around the world are stepping into the market, it is exhibiting bright prospects and immense opportunities to cash in on. According to “G-CSF Biosimilars Market Forecast to 2015”, the overall market is presently dominated by first-generation biosimilars, and it is likely that their second-generation will grow phenomenally in the future. The Granulocyte colony-stimulating factor (G-CSF) biologics/biosimilars stimulate the production of neutrophils. In 2010, the G-CSF biosimilars had a 33% share in the global biosimilars market. It is expected that the patent expiries of Neupogen (filgrastim) in 2013 and Neulasta (pegfilgrastim) in 2015 will make the way for the entry of G-CSF biosimilars into the market. It is anticipated that the G-CSF biosimilars market will touch the US$ 350 Million-mark by 2015.

  3. Table of Contents: 1. Analyst View 2. Research Methodology 3. Biologics Market Outlook to 2015 3.1 Market Size 3.2 Market Segmentation 4. Market Trends & Drivers 4.1 Rising Business Alliances Aiding in Biosimilar Development 4.2 Governments Realizing the Potential in Biosimilars, Encouraging Industry Growth 4.3 Biosimilar Players in US to Prefer BLA over Abbreviated Pathway 5. Biosimilars Market Outlook to 2015 6. Global G-CSF Biosimilars Market Forecast to 2015 6.1 Scientific Insight 6.2 Market Analysis 6.3 Recent Activities

  4. For more information: Bharat Book Bureau Phone : +91 22 27810772, 27810773 Fax : +91 22 27812290 E-mail : info@bharatbook.com Website : www.bharatbook.com • Kindly click on : http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/g-csf-biosimilars-market-forecast-to-2015.html Or visit

More Related